Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Pancreatic Fistula 1Duodenal Neoplasms 1

Interventions

Specimen Handling 625pembrolizumab 606Magnetic Resonance Spectroscopy 550Carboplatin 448Cisplatin 396Cyclophosphamide 394Biopsy 371Paclitaxel 323Nivolumab 322Gemcitabine 317Radiotherapy 283Bevacizumab 242Dexamethasone 222fludarabine 213Docetaxel 198durvalumab 194Oxaliplatin 187venetoclax 186atezolizumab 179Fluorouracil 176Rituximab 175Pemetrexed 172Capecitabine 167Radiation 164Doxorubicin 164Radiosurgery 159Ipilimumab 145Etoposide 142Leucovorin 140Lenalidomide 138

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Pancreaticojejunostomy × 90 days × Clear all
NCT06630910 2026-03-31

whipple

Theodor Bilharz Research Institute

Phase NA Completed
48 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

NCT06756074 2026-03-16

Reinforced Pancreaticojejunostomy With or Without glubran2

Minia University

Phase 2 Recruiting
100 enrolled
Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡